CellGenic CJC-1295 + Ipamorelin combines two researched peptides commonly studied for their role in growth hormone pathway modulation. This formulation is designed for qualified research environments investigating peptide interactions, metabolic signaling, recovery models, and cellular response pathways.
Each product is manufactured under controlled laboratory standards with quality documentation available for verified research professionals.
835 in stock
PEPTIDE DOSE: Select dose
DRAW SYRINGE TO: Select values
YOUR VIAL CONTAINS: Select values
CONCENTRATION: Select values
CJC-1295 and Ipamorelin are research peptides studied for their interaction with growth hormone-related signaling pathways. CJC-1295 is a growth hormone-releasing hormone (GHRH) analog, while Ipamorelin is a growth hormone secretagogue studied for selective activity on ghrelin-related pathways.
This combination is researched in laboratory models focused on peptide signaling, metabolic function, tissue response, and cellular communication.
Apply once, get reviewed by our team, and access provider-only pricing across peptides, exosomes, and cellular products.
PRODUCT USAGE: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product is intended strictly for laboratory research and qualifies under appropriate regulatory frameworks for research-only use. It is not intended to diagnose, treat, cure, or prevent any disease or condition. This product should only be handled by licensed, qualified professionals. It is not intended for use by the general public. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
